<?xml version="1.0" encoding="UTF-8"?>
<p>The most commonly reported clinical symptoms of COVID-19 among approximately 14,000 cases reported to the European Surveillance System have been fever (47%), dry or productive cough (25%), sore throat (16%), general weakness (6%), and pain (5%) [
 <xref ref-type="bibr" rid="CR1">1</xref>]. Diagnostic suspicion is generally made on clinical signs and symptoms (fever, fatigue, dry cough, anorexia, dyspnea, rhinorrhea, ageusia, anosmia) and confirmed by polymerase chain reaction tests on nasopharyngeal and oropharyngeal swabs or sputum. There are preliminary reports of skin involvement (erythematous rashes, widespread urticaria, and chickenpox-like vesicles) occurring in 20% of patients in the course of the disease [
 <xref ref-type="bibr" rid="CR11">11</xref>]. Hospitalization, generally due to pneumonitis, occurred in 30% of cases; severe illness (requiring intensive care unit and/or respiratory support) was reported in 15% of hospitalized cases, and death in 12%. Both hospitalization and mortality rates increase steeply in patients aged 60Â years and above [
 <xref ref-type="bibr" rid="CR1">1</xref>].
</p>
